Thirty years of NCI thyroid cancer research investment (1996-2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution.

Jiang Y, Chen Y, Lai X, Le F

Open source

DOI
10.3389/fonc.2026.1876183
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1876183,
  title = {Thirty years of NCI thyroid cancer research investment (1996-2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution.},
  author = {Jiang Y and Chen Y and Lai X and Le F},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1876183},
  url = {https://doi.org/10.3389/fonc.2026.1876183}
}

RIS

TY  - JOUR
TI  - Thirty years of NCI thyroid cancer research investment (1996-2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution.
AU  - Jiang Y
AU  - Chen Y
AU  - Lai X
AU  - Le F
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1876183
UR  - https://doi.org/10.3389/fonc.2026.1876183
ER  - 

APA

Y, J., Y, C., X, L., & F, L. (2026). Thirty years of NCI thyroid cancer research investment (1996-2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1876183

Source records